Roger Ulrich
InvestorSenior Advisor at Frazier Life Sciences · Scientific Advisor at BioGeneration Ventures · Senior Advisor at Frazier Healthcare Partners
Greater Seattle Area
About
Roger Ulrich is a biotech executive and entrepreneur with experience in drug discovery and development, regulatory affairs, company formation, and financing. He serves as a board member at Telios Pharma, Inc.
Experience
- Telios Pharma, Inc.Member Board of Directorscurrent2019 — present
- Kartos Therapeutics, Inc.Member Board of Directorscurrent2018 — presentRedwood City, California, United States
- BGV (BioGeneration Ventures)Scientific Advisorcurrent2017 — presentThe Randstad, Netherlands
- Frazier Healthcare PartnersSenior Advisorcurrent2016 — presentGreater Seattle Area
- Link ImmunotherapeuticsChairman, Board Of Directors2019 — 2023Seattle, Washington, United States
- Lengo TherapeuticsBoard Of Directors2019 — 2021
- Acerta Pharma B.V. (A member of the AstraZeneca Group)Board of Directors and Chief Scientific Officer2013 — 2021
- Phathom Pharmaceuticals Inc.Chief Scientific Officer and Co-Founder2019 — 2021Greater Seattle Area
- Gilead SciencesOncology Research and Development2011 — 2012Greater Seattle Area
- Calistoga PharmaceuticalsFounder and Chief Development Officer2006 — 2011Seattle, Washington
- MerckSenior Scientific Director2001 — 2006
- AbbottDirector, Drug Safety Evaluation1997 — 2001Abbott Park, Illinois
- The Upjohn Company, Pharmacia & Upjohn Inc.Senior Scientist1983 — 1997Kalamazoo, Michigan
- West Virginia UniversityHead, Analytical Microscopy Laboratory1978 — 1983
Skills & more
Lifesciences11Drug Development19Oncology43Clinical Development55Drug Discovery65Biotechnology34Clinical Trials31Toxicology11Immunohistochemistry4Cell7Molecular Biology15Translational Medicine
+12 more
PharmacologyPharmacokineticsCancerBiomarker DiscoveryBiomarkersAssay DevelopmentGeneticsImmunologyPharmaceutical IndustryBiochemistryLaboratoryGLPFrom Roger's professional profile.
Colleagues at Frazier Life Sciences
Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences
Anna H. Chen
Partner at Frazier Life Sciences
Frequently asked questions
- Who is Roger Ulrich?
- Roger Ulrich is a biotech executive and entrepreneur with experience in drug discovery and development, regulatory affairs, company formation, and financing. He serves as a board member at Telios Pharma, Inc.
- Where does Roger Ulrich work?
- Roger Ulrich is Senior Advisor at Frazier Life Sciences.
- Where did Roger Ulrich go to school?
- Roger Ulrich studied at West Virginia University (PhD, Cell and Molecular Biology); Western Michigan University (Master of Science - MS, Biomedical); Western Michigan University (Bachelor of Science - BS, Biology/Chemistry).
Same school
Also attended West Virginia University28
Josephine LuschInvestment Associate at Burda Principal InvestmentsLaura VrcekInvestor at True VenturesMelissa BodensieckInvestor at True VenturesTim BaroneCo-Founder, Hunted Labs at Red Cell IncubationDan WeinbergPartner, DTC at MidnightChris BostickPartner at OCV Partners
+ 22 more
Also attended Western Michigan University26
George HoyemVenture Partner at Lavrock VenturesSerena YangSenior Analyst, Portfolio Operations at Northpond VenturesNakesha JasperExecutive Assistant at Permanent Capital VenturesJeff RinveltPartner at Renaissance Venture CapitalThien BuiManager, Venture Platform Services at Rev1 VenturesDeepak MenonAdvisor at Michigan Capital Network
+ 20 more
Shared employers
Also worked at Kartos Therapeutics, Inc.2
Also worked at Acerta Pharma B.V. (A member of the AstraZeneca Group)3
Also worked at Gilead Sciences30
Uri LopatinInvestor at Khosla VenturesJay ParrishVenture Partner at ARCH Venture PartnersPatrick LoerchBio Advisor at Amplify PartnersLaura QuockCBO-in-Residence at Versant VenturesBryan BergInvestor at Standard CapitalLan WuAnalyst at Fusion
+ 24 more
